From: Transcriptomic evidence of a para-inflammatory state in the middle aged lumbar spinal cord
Pathway | Target Genes | Pathway Genes | Ratio | z-score | B-H p value | Target Gene ID’s |
---|---|---|---|---|---|---|
Complement | 9 | 37 | 0.243 | 1.414 | 1.11E-06 | C3, C1QA, C1QB, C1QC, C1S, CFD, CFH, ITGB2, SERPING1 |
Cholesterol Biosynthesis | 7 | 28 | 0.250 | Â | 2.63E-05 | CYP51A1, HMGCR, HMGCS1, HSD17B7, IDI1, LSS, SC5D |
iCOS-iCOSL signaling T helper cell | 10 | 108 | 0.093 | Â | 6.64E-04 | CAMK2B, CD3G, FCER1G, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5, PDPK1, PLEKHA4, PTPRC |
Cholesterol Biosynthesis I | 4 | 13 | 0.308 | Â | 1.84E-03 | CYP51A1, HSD17B7, LSS, SC5D |
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol) | 4 | 13 | 0.308 | Â | 1.84E-03 | CYP51A1, HSD17B7, LSS, SC5D |
Cholesterol Biosynthesis II (via desmosterol) | 4 | 13 | 0.308 | Â | 1.84E-03 | CYP51A1, HSD17B7, LSS, SC5D |
Ca-induced T cell Apoptosis | 7 | 64 | 0.109 | Â | 2.40E-03 | CD3G, FCER1G, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5, PRKCE |
OX40-signaling | 8 | 89 | 0.090 | Â | 2.40E-03 | CD3G, FCER1G, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5, RT1-EC2, TNFSF4 |
NFAT regulation of immune response | 11 | 171 | 0.064 | 1.89 | 2.40E-03 | BLNK, CD3G, FCER1G, FCGR2B, FCGR3A/FCGR3B, GNAS, GSK3B, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5 |
B Cell development | 5 | 33 | 0.152 | Â | 4.35E-03 | HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5, PTPRC |
Nur77 signaling in T cells | 6 | 57 | 0.105 | Â | 6.70E-03 | CD3G, FCER1G, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5 |
Cd28 signaling in T Helper Cells | 8 | 118 | 0.068 | Â | 1.15E-02 | CD3G, FCER1G, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5, PDPK1, PTPRC |
PKC-Ï„ signaling in T cells | 8 | 118 | 0.068 | 1.414 | 1.15E-02 | CAMK2B, CD3G, FCER1G, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB5, MAP3K8 |